Sol-Gel Technologies (SLGL) Current Leases (2019 - 2026)
Sol-Gel Technologies (SLGL) reported Current Leases of $485000.0 for Q1 2026, up 12.01% year-over-year from $433000.0 in Q1 2025, and down 2.02% quarter-over-quarter from $495000.0 in Q4 2025.
Sol-Gel Technologies (SLGL) Current Leases (2019 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has 8 years of Current Leases data on file, last reported at $485000.0 in Q1 2026.
- Current Leases for Q1 2026 came in at $485000.0, up 12.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $485000.0 (up 12.01% YoY), and the FY2025 annual result was $495000.0, up 15.12% from the prior year.
- Current Leases fell to $485000.0 in Q1 2026 per SLGL's latest filing, from $495000.0 in the prior quarter.
- Over five years, Current Leases peaked at $766000.0 in Q1 2022 and troughed at $376000.0 in Q2 2024.
- A 5-year average of $513352.9 and a median of $482000.0 in 2025 frame the typical range for Current Leases.
- The sharpest annual moves came in 2023 and 2025: Current Leases slumped 38.23% in 2023, then rose 28.19% in 2025.
- A 5-year view of Current Leases shows it stood at $718000.0 in 2022, then plunged by 37.74% to $447000.0 in 2023, then dropped by 3.8% to $430000.0 in 2024, then grew by 15.12% to $495000.0 in 2025, then declined by 2.02% to $485000.0 in 2026.
- Business Quant data shows SLGL's Current Leases at $485000.0 in Q1 2026, $495000.0 in Q4 2025, and $491000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Sol-Gel Technologies | 207.80 Mn | 197.67 Mn | - | 485,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 485,000.00 |
| Dec 31, 2025 | 495,000.00 |
| Sep 30, 2025 | 491,000.00 |
| Jun 30, 2025 | 482,000.00 |
| Mar 31, 2025 | 433,000.00 |
| Dec 31, 2024 | 430,000.00 |
| Sep 30, 2024 | 384,000.00 |
| Jun 30, 2024 | 376,000.00 |
| Mar 31, 2024 | 386,000.00 |
| Dec 31, 2023 | 447,000.00 |
| Sep 30, 2023 | 467,000.00 |
| Jun 30, 2023 | 433,000.00 |
| Mar 31, 2023 | 544,000.00 |
| Dec 31, 2022 | 718,000.00 |
| Sep 30, 2022 | 689,000.00 |
| Jun 30, 2022 | 701,000.00 |
| Mar 31, 2022 | 766,000.00 |
| Dec 31, 2021 | 781,000.00 |
| Sep 30, 2021 | 652,000.00 |
| Jun 30, 2021 | 649,000.00 |